                         SEQUENCE LISTING

<110>  UCL Business PLC
 
<120>  Diabetes Gene Therapy

<130>  P531144PCTJW

<150>  1517329.7
<151>  2015-09-30

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  333
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Nucleotide sequence of codon optimised insulin gene

<400>  1
atggctcttt ggatgagact gcttcctctg cttgctctgc tggccctctg gggacctgat       60

cctgctgctg cctttgtgaa tcagcatctg tgcggctccg atcttgtgga agctctgtat      120

cttgtgtgcg gagaaagagg ctttttttac acacccagga cccgccggga agccgaagac      180

ctgcaggtgg ggcaggtgga gctgggaggc ggacctggag ccggcagcct gcagcccttg      240

gccctggagg ggtcccggca gaagcgtggc atcgtggaac agtgctgcac ctccatctgc      300

tccctgtatc agctggaaaa ttattgcaat tag                                   333


<210>  2
<211>  110
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Ala Leu Trp Met Arg Leu Leu Pro Leu Leu Ala Leu Leu Ala Leu 
1               5                   10                  15      


Trp Gly Pro Asp Pro Ala Ala Ala Phe Val Asn Gln His Leu Cys Gly 
            20                  25                  30          


Ser Asp Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe 
        35                  40                  45              


Phe Tyr Thr Pro Arg Thr Arg Arg Glu Ala Glu Asp Leu Gln Val Gly 
    50                  55                  60                  


Gln Val Glu Leu Gly Gly Gly Pro Gly Ala Gly Ser Leu Gln Pro Leu 
65                  70                  75                  80  


Ala Leu Glu Gly Ser Arg Gln Lys Arg Gly Ile Val Glu Gln Cys Cys 
                85                  90                  95      


Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Asn 
            100                 105                 110 


